Single vs. Multiple-Set Resistance Training in Sedentary Men (NCT07337304) | Clinical Trial Compass
CompletedNot Applicable
Single vs. Multiple-Set Resistance Training in Sedentary Men
Turkey (Türkiye)34 participantsStarted 2022-08-01
Plain-language summary
This study aimed to compare the effects of single-set versus multiple-set resistance training on neuromuscular performance and muscle morphology in sedentary men. Participants were randomly assigned to a single-set training group, a multiple-set training group, or a non-training control group. The intervention consisted of a structured resistance training program performed over a defined training period, while the control group maintained their usual lifestyle without structured exercise. Neuromuscular performance outcomes included maximal strength and functional performance measures, and muscle morphology was assessed using appropriate imaging and anthropometric methods. The findings of this study are intended to contribute to the understanding of optimal resistance training volume for improving neuromuscular adaptations in previously untrained individuals.
Who can participate
Age range
18 Years – 40 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male participants aged between 18 and 40 years
* Sedentary lifestyle (no structured resistance training in the previous 6 months)
* Apparently healthy, with no known cardiovascular, metabolic, or musculoskeletal disorders
* Ability to participate in resistance training exercise
* Willingness to provide written informed consent
Exclusion Criteria:
* Participation in regular resistance or structured exercise training within the past 6 months
* History of musculoskeletal injury or surgery that could limit exercise performance
* Presence of cardiovascular, neurological, or metabolic disease
* Use of medications or supplements known to affect muscle function or performance
* Any condition deemed unsafe for participation by the investigators
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.